Physician profile
Kaitlin Lee
NPI 1710203666
$501.65
in general payments reported to CMS, 2019-2025
15 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.87 · 2020: $18.08 · 2022: $36.41 · 2023: $127 · 2024: $81.00 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $117.43 | 2025 | Myosure Tissue Removal Device, Novasure, Fluent Fluid Management System |
| Bayer Healthcare Pharmaceuticals INC. | $82.58 | 2023-2025 | |
| Exact Sciences Corporation | $42.98 | 2023 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $42.74 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $34.57 | 2023 | Veozah |
| Sumitomo Pharma America, INC. | $24.75 | 2024 | Gemtesa |
| Supernus Pharmaceuticals, INC. | $20.44 | 2025 | Qelbree |
| Coopersurgical, INC. | $20.36 | 2024 | Paragard T 380a |
| Abbvie INC. | $18.64 | 2022 | |
| Meditrina | $18.08 | 2020 | |
| Organon LLC | $17.77 | 2022 | |
| Merck Sharp & Dohme LLC | $17.22 | 2019 | |
| Pfizer INC. | $15.65 | 2019 | |
| Shield Therapeutics INC | $15.58 | 2023 | Accrufer |
| Medline Industries LP | $12.86 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.